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ABSTRACT

Non-toxic biosensors are encountering an increase in attention for use in
understanding the fate of cells and as a diagnostic tool. Development and
incorporation of suitable fluorophores into biological molecules is the key for
monitoring proteins in vivo research. This study investigated the enhanced
emission of Eu (III) and Tb (III) upon binding to the four DNA bases and their
respective nucleotides, found the best ratio for effective energy transfer, and
developing nanoparticles to deliver the biosensor into the cells.

It is well known that Eu (III) and Tb (III) exhibit very distinctive photocharacteristics. The luminescence of these two lanthanides is weak due to low
absorption cross sections. Conversely, the emission of both trivalent ions, upon
irradiation, in aqueous solution, is strong when bound to complex ligand systems.
The luminescent enhancement is the result of energy transfer (EnT) and the
binding with single-stranded DNA, making these ions perfect candidates for
luminescent probes

(1)

.

The emission lanthanides theory by G.A. Crosby

establishes that the intramolecular energy transfer in a lanthanide complex is
when the lowest triplet state energy level of the complex equals or lies above the
resonance level of the lanthanide (2)

xi

To overcome the inherently low absorption of lanthanide ions, researchers have
developed sensitizing fluorophores that upon excitation, transfer energy to the
lanthanide (3) (4). One problem with luminescence in an aqueous solution is that
another pathway is available for deactivation of the excited state of the lanthanide,
in the form of vibrational energy transfer to water molecules

(1).

Early research

shows that quenching of luminescence is minimized by using ligands which
tended to encapsulate the lanthanide ion (1). Longer emission lifetimes and greater
quantum yield intensities can be accomplished by either chelation by ligands (5) or
encapsulation of the lanthanides. We ascertained the maximum enhancement for
the lanthanide ions occurred through the interaction with the base guanine or its
nucleotide guanosine 5’-monophosphate disodium salt.

The research initially pursued the encapsulation of the lanthanide ions by singlestrand oligonucleotides as a biosensor. However, an alternative delivery method
based on inverse micelles and liposomes was developed and it proved to be
economical and simple to encapsulate and deliver the biosensor into the cells.
The creation of a double emulsion, or water-oil-water system, and the
encapsulation (using palmitic acid as surfactant) of the water soluble biosensors
were successful. This thesis determined the particle size achieved of 75nm, for
both lanthanides had fallen into the nanoemulsions range.
permits the nanoparticles to be injected intravenously (6).

xii

Their small size

The in vitro toxicity of the nanoparticles, with both luminescence biosensors, was
assessed by BCA assay.

Results supported both luminescence nanoparticles

biosensors were non toxic to human cells. Therefore, these NP’s have a potential
to provide a unique detection signature as a contrast agent suitable for medical
applications (7).

It has been published that nanoparticles (NPs) can rapidly be transported to the
liver (about 90%), then kidneys and other organs (8). After a period of time, the
NPs are expelled from the human body through feces and urine, unless the size of
the NPs is larger than 200 nm, in which case the NPs are retained / trapped by the
liver. The particle size obtained in this research, 75nm, is a good indication that
the biosensor will have a safe disposal from the body.

xiii
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1.

INTRODUCTION

Non-toxic biosensors are experiencing an increase interest due to the need to
understand the fate of cells and as a diagnostic tool. Development and
incorporation of appropriate fluorophores into biological molecules is the key for
proteins in vivo research. It is well known that Eu (III) and Tb (III) exhibit very
unique photo-characteristics upon irradiation.

It has been shown that the emissive lanthanide properties of Eu (III) and Tb (III),
including their luminescence enhancement through energy transfer, and their
ability to bind single-stranded regions of DNA make these ions the perfect
candidates

for

life-cell

imaging

system.

Additionally,

single-stranded

oligonucleotides are known to enhance the emission of Eu (III) and Tb (III) ions
in solution

(1)

. Previous studies have confirmed that lanthanide ions also bind

oligonucleotides (9) (10) , and the resulting bioconjugates provide in the monitoring
of hybridization reactions and phosphodiesterase activity by FRET, Föster
resonant energy transfer, technology (11) (12).
.
As stated earlier, it is well known that Eu (III) and Tb (III) exhibit very unique
photo-characteristics upon irradiation. To overcome the inherently low absorption
of lanthanide ions, researchers have developed sensitizing fluorophores that upon
excitation, transfer energy to the lanthanide (13) (4). There is a major problem with
luminescence in an aqueous solution that another pathway is available for
deactivation of the excited state of the lanthanide, in the form of vibrational

2
energy transfer to water molecules in particular. This quenching of luminescence
can be minimized by using ligands which tend to encapsulate the lanthanide ion
(1)

. To overcome the weak luminescence in aqueous solution of Eu (III) and Tb

(III), addition of chelating agents or encapsulation of the lanthanides leads to
longer emission lifetimes and quantum yields.

Our research pursues the encapsulation of the lanthanides. Encapsulation is to
protect the enclosed lanthanides from substances or processes in the vicinity of
these

capsules.

The

unique

optical

property

of

Eu(III)

and

Tb(III)

Nanoparticles(NP) will provide us a new live-cell imaging system which is safe,
photostable, and photosensitive. The stability both in the excited state and in
oxidation state makes these lanthanides good imaging molecules to monitor
cellular activities such as enzymatic reactivity, DNA hybridization, drug binding,
electron transfer, and nucleic acid solvation environment.

The ultimate goal of this thesis study is to develop a delivery mechanism that
packages theses two lanthanides into a biosensor, insert the biosensor into the
bloodstream and release it at the specific point of interest (14).

We discovered that the maximum enhancement for the lanthanide ions occurred
through the interaction with the base guanine (G) and the phosphate groups of its
nucleotide guanosine 5’-monophosphate disodium salt (GMP), (Figure 1 and 2).
It was found that guanine enhances both of the trivalent ions emission with Eu

3
(III) being more emissive. In accordance with literature research, energy transfer
from intrinsic fluorophores, such as nucleic acids, generally gave rise to enhanced
Eu (III) and Tb (III) emission (15). However, the results which are to be discussed
later, shows Eu (III) opposed this statement.

Although previous studies reported energy transfer from the bases (C and G) and
nucleotide 5’-deoxymonophosphate (dGMP), unexpected behavior of the 2’
deoxyguanosine 5’-triphosphate disodium salt (dGTP) nucleotide was found.
Actually, none of the triphosphate nucleotides enhanced the fluorescence of the
trivalent ions. Phosphate interference was determined as the main cause for
unsuccessful energy transfer. Research has shown that in the cases of G and
dGMP, the phosphate group appears to aid in the biding of the donor and
acceptor. A comparison of the enhanced luminescence among GMP with its
triphosphate and diphosphate analogues, GTP and GDP, respectively, has shown
that GMP is a better energy transfer donor in the order GMP> GDP > GTP (16) (17).
The results indicated that the lanthanide bounded to the monophosphate group
(GMP) was closer for effective energy transfer than the triphosphate groups
(dGTP). The degree of enhancement of GMP bound to Tb (III) was greater than
for Eu (III), respectively. The enhancement of the trivalent ions by GMP was
much greater than the base G.

Toxicity studies through BCA assay, (bicinchoninic acid), determined that our
nanosensors were non-cytotoxic.

The w/o/w double emulsion technique

4
successfully created nanoparticles which encapsulate the water soluble biosensor.
A TEM image showed that the size of the particle was 75 nm, which fell into the
nanoemulsions range (Figure 29).

The choice of the rare earths or lanthanides was not arbitrarily chosen. The rare
earths (RE) form a group of chemically similar elements which have in common
an open 4f shell. They are chiefly trivalent and it is principally the properties of
the trivalent ions which are important rather than those of the neutral atoms. They
are strongly paramagnetic, in some cases ferromagnetic or anti-ferromagnetic at
low temperatures. Their trivalent salts have absorption spectra and in some cases
fluorescence spectra with sharp lines in the visible or neighboring spectral regions
(27)

. Some trivalent lanthanide ions exhibit excellent luminescence characteristics

when the native luminescence is enhanced by coordination with suitable organic
ligands.

Having chosen the lanthanides Eu (III) and Tb (III), the design of the biosensor
was the next crucial step and was based on chemical, photo-physical and
biochemical guidelines published from literature research. For in vivo
experiments, the matter of toxicity is highly critical, as well as the ability of the
probe to be excreted in a reasonable span of time (typically 12-48 h). Lanthanides
are relatively innocuous due to poor absorption in the gastrointestinal track and,
even when injected, normally cannot penetrate living cells (19; 20). According to
the systematic studies published to date, extraordinary rules have been established

5
based on a simplistic model which the main energy transfer path implies the
ligand triplet state and that the only parameter of importance is the energy gap
between this state and the emitting Ln(III) level (21) (22) (23).

Figure 1. Structure of the four DNA bases
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Figure 2. Structure of dGTP & GMP Nucleotides
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1.a. Spectroscopic characteristics of Europium and Terbium

The trivalent ions of Eu (III) and Tb (III) show excellent luminescence
characteristics when enhanced by coordination with suitable ligands. The
enhancement of luminescence intensity by complexation of the tri-positive
luminescent lanthanide, Ln (III) ions, has been explained on the basis of a ligandto-metal energy transfer mechanism (24). The mechanism for energy transfer was
derived from research by Kasha, Crosby, and their co-workers (30) . (See Figure 3.)
When an excited triplet state of the coordinating ligand overlaps a lanthanide
excited electronic level, the lanthanide luminescence is pumped by a large cross
section molecular absorbance, rather than by its own weak absorbance. To
understand the photo-physics and photochemistry of the lanthanides see energy
level diagram, Figure 4.

(3)

This diagram illustrates the largest gaps in energy

level bands for Eu (III) and Tb (III). Eu (III) has a regular 7F multiplet as ground
multiplet followed by a 5D multiplet.

At low temperatures, the absorption

spectrum in the visible is due to the transitions from the ground state 7F0 to 5D0,
5

D1, 5D2, 5D3. Shortly above the level 5D3, a whole series of levels is found and

the situation is that the expected levels are so crowded that a detailed analysis is
difficult (27).

7
Figure 3. Schematic diagram of the ligand-to-lanthanide energy transfer (28).
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Figure 4. Energy Level Diagram

1.b. Nanoparticles Design for biosensor delivery

Nanoparticles were designed by utilizing the characteristic behavior of dual
structure, hydrophilic and hydrophobic region in a single molecule. The delivery
system must have the property of solubilizing the aqueous biosensor in a
hydrophilic (polar) micelle core. Using amphipathic molecules which are
everywhere in biological systems. The nanoparticles were designed by using
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inverse micelles and double emulsions (Figures 5, 6 and 7). Two particular
amphiphilic molecules were chosen. One was a synthetic surfactant: palmitic acid
which is anionic, has low toxicity and forms charged micelles that can bind to
oppositely charged particles. Second one was a membrane lipid: phospholipids,
particularly phosphatidylcholine, which is used for preparation of vesicle
suspensions commonly called liposomes or as monolayers

(34)

(Figure 5).

Effective delivery and release of the biosensor were the main purpose of the
nanoparticles design.

Palmitic acid or hexadecanoic acid was selected because it is one of the most
common saturated fatty acids found in animals and plants. Phospholipid micelles
were chosen due to the fact they are an ideal drug and biosensor carrier.

Figure 5. Liposome (35)
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Phospholipid micelles are ideal drug carrier systems for multiple reasons. First,
the phospholipid nanoparticles are biocompatible and biodegradable. Second,
preparation is simple and reproducible

(33)

. Finally, phospholipids improved in

vitro and in vivo stability, bioactivity, targetability and reduced toxicity (33).

Disadvantages are the body can identify the liposomes as foreign intruders and
destroy the delivery vehicle. Also, liposomes are very sensitive to temperature,
surfactant concentration, and moisture

The nanoparticles were formed by creating inverse micelles and then invert the
emulsion. The supramolecular living aggregates can be formed by dissolving
surfactants in strongly polar or totally apolar solvents (oils).

A schematic

representation of reversed micelle is shown in Figure 6.

As stated before the building blocks to our delivery mechanism are molecules
called amphiphiles. The strategy devised the use of amphiphiles introduced into
an oily liquid (forming reverse micelles) and then obtained a double emulsion.

11

Figure 6. Schematic Representation of a Reverse Micelle (35).

Figure 7. Schematic Representation of Water in Oil emulsion (39).
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The difference between reverse micelles and w/o microemulsions is that in the
micelles the emphasis is on the surfactant forming the aggregate, while in
microemulsions the amount of solubilizate compartmentalize in the micellar core
constitutes a relevant part of the entire aggregate.

It is one thing to produce nanoemulsions, it is another thing to determine if they
were formed. Different methods such as NMR self-diffusion, transmission
electron microscopy (TEM) and scattering techniques (small angle X-ray
scattering (SAXS)) and small angle neutron scattering (SANS) provide
information of the structure and dynamics of microemulsions and nanoemulsions.

Size and shape of a droplet microemulsions and nanoemulsions can be
investigated using a combination of different scattering techniques. Small angle
neutron scattering (SANS) is an excellent tool to study the shape, size and
polydispersity of the microemulsion droplets. The translational diffusion of the
droplets can be studied using dynamic light scattering (DLS). Finally, neutron
spin-echo spectroscopy (NSE) gives direct access to the shape fluctuations of the
droplets (40).
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2.

MATERIALS AND METHODS

2. a. Materials
Materials were obtained from commercial suppliers and used without further
purification. Analytical reagent grade chemicals were used along with de-ionized
water to prepare solutions. Lanthanides chlorides were obtained in purities of
99%. Stock solutions of different concentrations of the lanthanides were prepared
by dissolving a known amount of trivalent ions in PBS or water (refers to table 1
and table 2). A series of serial dilutions were made with PBS at first for the
triphosphate nucleotides and later with de-ionized water, for both the triphosphate
and monophosphate nucleotides.

Lanthanides
•

Europium(III) chloride powder, EuCl3,
Purity: 99.9%; was obtained from Aldrich.
F.W=258.3, Lot number: 05585JJ,
Appearance: pale yellow powder. CAS 10025-76-0, mp 850 OC

•

Terbium(III) chloride anhydrous powder, TbCl3,
Purity: 99.9% was obtained from Aldrich.
F.W=265.28, Lot number: MKAA3919,
Appearance: white powder. CAS 10042-88-3 mp 588 OC.
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Nucleotides:
•

2’ Deoxyadenosine 5’-triphosphate disodium salt (dATP), 97%, F.W=
535.15 Sigma Aldrich D6500-10MG

•

2’ Deoxycytidine

5’-triphosphate disodium salt (dCTP), 95%, F.W=

511.1 Sigma Aldrich D4635-10MG 98% Purity (HPLC); 4 % Solvent;
•

2’

Deoxyguanosine

5’-triphosphate

sodium

salt

(dGTP),

96%,

F.W=507.18 Sigma Aldrich D4010-10MG
•

2’ Deoxythymidine 5’-triphosphate sodium salt (dTTP), 96%, F.W=482.2
Sigma Aldrich T0251-10MG

•

Adenosine 5’-monophosphate disodium salt (AMP), 99%, F.W=391.18,
from Biochemika-Fluka Analytical 01930-5G C10H12N5Na2O7P, Lot
0001443266

•

Cytidine 5’-monophosphate disodium salt (CMP), 99%, F.W=367.16,
from Sigma C1006-1G C9H12N3Na2O8P, Lot 109K1631

•

Guanosine 5’-monophosphate disodium salt (GMP), 99%, F.W=407.18,
from Sigma G8377-5G C10H12N5Na2O8P x H2O, Lot BCBB5515

•

Thymidine 5’-monophosphate disodium salt (TMP), 99%, F.W=366.17
from Sigma T7004-250MG C10H13N2Na2O8P, Lot 129K1338V
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Nucleobases
All were obtained from Sigma Aldrich
•

Adenine A8628-5G, C5H5N5, 99%: , F.W=135.13, Lot 108K0136

•

Cytosine C3506-5G, C4H5N3O, 99%:, F.W= 111.1, Lot 059K1010

•

Guanine G11950-25G, C5H5N5O, 98%, F.W= 151.13, Lot 03420LH

•

Thymine T0895-5G, C5H6N202, 99%, F.W=126.11, Lot 0001435947

PBS
PBS 1X Phosphate Buffered Saline solution without calcium & magnesium, pH:
7.36, obtained from Cellgro Mediatech Inc. CAT No. 21-040-CV
From scratch take the following to make 500 mL solution:
10.9g Na2HPO4
3.2g NaH2PO4
90g NaCl
500mL distilled H2O
To adjust the pH add NaOH until final pH = 7.36

Nanoparticles
•

α-Tocopherol, F.W=472.74, density=0.953 g/ml, Lot No. 1320538 was
obtained from Fluka

•

L-A Phosphaditylcholine, obtained from Sigma Aldrich, F.W=776 g/mol,
CAS No. 8002-43-5, Lot No. 119K5200, (See attachment 1 for MSDS)
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•

Palmitic Acid (Hexadecanoic Acid), obtained from Sigma appox 99%, No
P-0500 chemical formula is CH3(CH2)14COOH Anhyd mol wt 256.4 Lot
42F-0615, (See attachment 1 for MSDS

•

Adherent cell Lysis solution was obtained from Origene, hypotonic lysis
buffer lot No. 1010

•

N-Lauroylsarcosine sodium salt for Molecular Biology (Warning use
Mask) from Sigma life sciences Pcode 1000678233, CAS-137-16-6,
C15H28NNaO3, MW=293.38g Assay Spec >94% (used 2g in 10mL H2O)

•

BCATM Protein Assay Kit (bicinchoninic acid) obtained from Thermo
Scientific product # 23225 Lot KL136078. BCATM Protein Assay is
shown in Figure 8
Contains:
Product #23228 BCA Protein Assay Reagent A
Product # 1859078 BCA Protein Assay Reagent B
Prepared the working reagent by mixing 50 parts of BCA Reagent A with
1 part of BCA Reagent B.

•

Hs27 Foreskin Human (Homo sapiens) from ATCC product code CRL1634 lot number 4012887 1mL volume ampoule containing 8.4 x 105
cells. Tissue: Normal; foreskin. Age: Newborn. Gender: male.
Morphology: fibroblast. Date frozen: 02/25/05. Expected Viability: 95%
to 100%.
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•

Thermo Scientific Hyclone Classical Liquid Media Dulbeccos Modified
Eagles Medium (DMEM) / High Glucose; without L-Glutamine and
Sodium Pyruvate. Media; Cell culture; Liquid; Phenol Red. Catalog
number SH30081.FS

•

Standard Fetal Bovine Serum Collected and processed in USA by
HyClone. Triple 0.1 um Sterile Filtered Cat # SH30088.03

•

Amphotericin B Solution obtained from Sigma A2942

100mL

250

μg/mL, Lot 0109M00052
•

Gentamycin solution from Sigma 10mg/mL in deionized water, liquid,
sterile-filtered, BioReagent, suitable for cell culture. Prod # G1272

•

Trypsin 10x solution from Sigma T4549 Sterile filtered

•

PLGA – Poly(DL-Lactide-Co-glycolide)(50:50), inherit viscosity 0.15 –
0.25 Aldrich 531154-16 mk BB7347

•

PEG – Polyethylene glycol from Sigma-Aldrich P3015-500g Batch #
029K0174, CAS 25322-68-3

•

PVA – Polyvinyl Alcohol 98% hydrolyzed, from Aldrich 348406-25G
Lot 04904DJ CAS# 9002-89-5
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Figure 8. BCA Reagent

•
•

http://www.piercenet.com/
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INSTRUMENTATION.
All UV-Vis absorption intensity measurements were measured on Ocean Optics
USB4000-UV-VIS

(USB4F07697)

and

USB-ISS-UV/VIS

(UUSC1562).

Software to plot excitation and emission spectra was Logger Pro 3.8.2 Ver. Dtd.
Feb 11, 2010 ISBN- 1-929075-24-3.
Figure 9. Ocean Optics UV-Vis Spectrophotometer

All luminescence intensity measurements were made on a Ocean Optics USB
2000+, CuV, PX-2 spectrophotometer equipped with Spectra Suite Spectroscopy
Software 2008 for o/s Win XP ver. 5.1 running X86. The USB2000+ Miniature
Fiber Optic Spectrometer is a powerful 2-MHz analog-to-digital (A/D) converter,
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programmable electronics, a 2048-element CCD-array detector, and a high-speed
USB 2.0 port.
The PX-2 Pulsed Xenon Light Source was a high flash rate, short-arc xenon lamp
for

applications

involving

absorbance,

reflection,

fluorescence

and

phosphorescence measurements. Fluoremeter, integration time 2 sec, Scans to
average 10, Boxcar width 10.
Both sets of measurements used 1.0 cm quartz cuvettes.

21

Figure 10. Ocean Optics USB2000 spectrophotometer
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To obtain data of emission of the nanoparticles in the cells, the BioTek El x800
with Gen 5 1.09 software to read @ 570 & 630, two times 24 well plate was used.

Figure 11. Bio Tek Fluorometer

http://www.biotek.com/
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Finally to obtain the picture of the fluorescence nanoparticles inside the cells, the
Olympus BX51 quality research microscope was used. This instrument is capable
of bright-field, dark-field, fluorescence, phase contrast and differential
interference contrast (Normarski DIC) viewing of samples. The DP 70 Digital
Camera was used in conjunction with Olympus DP manager and DP Controller
Software.

Figure 12. Olympus BX51 Microscope

24

2.B. Methods
To find out which nuclei base and nucleotide absorbs and/or emits the best for
effective energy transfer; intensity of absorption was measured. Then, emissions
were measured after titration of lanthanides with each one of the nucleobases and
nucleotides, respectively. The absorption was performed using the Ocean Optics
USB 4000-UV-VIS. Solutions were prepared in the dark, due to materials
photosensitivity. Logger Pro 3.8.2 software was used to collect the data. Once in
Logger Pro, experiment was picked, calibration was performed with a blank and
once calibrated; data was collected, and exported as text to graph later. In the
same way emission was performed using Ocean Optics USB 2000+,
spectrophotometer equipped with Spectra Suite Spectroscopy Software 2008

Originally, the Stock solutions were prepared in PBS shown in Table 1.
Performed the UV/Vis measurements, but realized when executing the procedure
on the spectrophotometer, the phosphate in the PBS would interfere with the
luminescence.

Stock solutions were redone in de-ionized water for the

nucleotides at 5mM and nucleobases at 10mM, Table 2 shows the real
concentrations obtained.

Afterwards, diluted the Bases to 100µM, 200µM,

500µM and 1000µM, in addition, the nucleotides stock solutions were diluted to
50 µM and 100µM, and then measured UV-Vis for all of them. In Table 3, the
monophosphates nucleotides Stock solutions were prepared using de-ionized
water. These nucleotides were used at a diluted concentration of 1mM when
combined with the respective lanthanides.
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The process called “titration of the lanthanide” was performed as follows:
prepared stock solutions in de-ionized water for EuCl3 at 9.80mM, then diluted
them to 100µM , 200µM, 500µM, 1,000 µM; likewise TbCl3 at 10.05 mM was
diluted to 100µM, 200µM. The two lanthanides were diluted to a concentration of
40 µM.

Table 1. Stock Solutions Bases and Triphosphates in PBS
Nucleotide/Nucleobase

Stock Solution
(concentration mM)

DATP

4.95

DCTP

5.02

DGTP

5.05

DTTP

5.11

Adenine

10.01

Cytosine

11.58

Guanine

10.59

Thymine

9.68

Placed 2mL of EuCl3 or then TbCl3 of the specified 40 µM concentration into a
cuvette and titrated with each one of the nucleobases respectively, in increments
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of 10 µL until the peak point of the curve had been reached, or stopped if the
absorption/emission readings followed cycles without reaching a peak.

Table 2. Stock Solutions Bases and Triphosphates

Nucleotide/Nucleobase

Stock Solution

Dilution

Wavelenght

(mM)

mM

ʎ

DATP

8.69

1

375.81

DCTP

5.39

1

375.81

DGTP

3.21

1

486.82,
529.32 &
542.54

DTTP

3.38

1

375.81

Adenine

9.88

1

375.81

Cytosine

10.03

1

375.81

Guanine

10.00

486.82,
1

529.32 &
542.54

Thymine

10.05

1

375.81

Placed 2ml of EuCl3, then TbCl3 of the specified 40 µM concentration in a cuvette
and titrated with each one nucleotides respectively, in increments of 10 µL until
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the peak point of the curve had been reached, or stopped if the
absorption/emission readings followed cycles without reaching a peak .The
dilution concentrations of the triphosphates and bases were at 1 mM.
Table 3. Stock Solutions Monophosphates

Nucleotide/Nucleobase

Stock Solution

Dilution

Wavelenght

(mM)

mM

ʎ

AMP

9.97

1

375.81

CMP

10.07

1

375.81

GMP

10.00

1

486.82,
529.32

&

542.54
TMP

10.01

1

375.81

Stock solutions were prepared in de-ionized water for EuCl3 at 8.17mM and TbCl3
at 8.04mM. The two lanthanides were diluted to a concentration of 40 µM when
placed in a cuvette for measurements.

Placed 2mL of EuCl3 of the specified 40 µM concentration into a cuvette and
titrated with each one of the mono nucleotides in increments of 10 µL until the
peak point of the curve had been reached, or stopped if the absorption/emission
readings followed cycles without reaching a peak.

28
Preparation of Nanoparticles
During our research two different kinds of Nanoparticles were prepared. The first
one was based on Governors State University thesis research by authors Bandaru
and Fu. The researchers developed nanoparticles with PLGA-PEG polymer
combination to increase the hydrophilicity of Rifampicin (RIF), a hydrophobic
drug

(26)

.

Their work, “Photo Physical Properties of Non- Encapsulated and

Encapsulated Rifampicin: A comparative study”, was the base for becoming
familiar with the methods and measurement of fluorescence nanoparticles. The
hydrophobic nanoparticle was not a good fit for this research but helped to
understand the delivery mechanism into the cells.

The second type of

nanoparticles developed was based on nanoemulsion technology using two
different types of surfactants. Following is the description of the two methods
pursued to develop hydrophobic and hydrophilic nanoparticles.

Preparation of Nanoparticles with luminescence marker (Rivoflavin+Rifampicin)
(26)

•

A calculated amount of Poly (DL-Lactide-Co-glycolide (PLGA) and 5%
(w/v) polyethylene glycol (PEG) were dissolved in 2 mL of
dichloromethane (DCM) in separate tubes. Then mixed for 30 minutes.

•

Prepared luminescence marker Rifampicin (RIF)

•

Prepared PVA solution.

•

The luminescence marker and the polymer solution PLGA and PEG were
mixed and vortexed until emulsified.
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•

The emulsion was poured into PVA solution which led to the double
emulsification of the particles.

•

Mixture from previous step was sonicated for 30 minutes then centrifuged
for 15 minutes at 13000 rpm, washed with de-ionized water twice.
Repeated centrifugation step 4 times, then resuspended in water and
placed in the refrigerator for storage.

Preparation of W/O/W Nanoparticles with luminescence Lanthanide marker
The following drug delivery system allows the encapsulation of hydrophilic
species into nanoemulsions.

The reverse-micellar system involved the

solubilization of hydrophilic molecules (solutions of Eu3+ and Tb3+ with
Guanosine 5’-monophosphate disodium salt hydrate (GMP), respectively, in oil
(α-Tocopherol) to form a stable w/o emulsions (encapsulation of the marker).
The reverse micelle–loaded oil was injected into an aqueous phospholipid or
palmitic acid solution to form a w/o/w emulsion.

The phase-transfer method for preparation of reverse micelles (27) was pursued. In
this method the organic phase (oil) loaded with L-α Phosphaditylcholine or
palmitic acid (surfactants) was titrated with the luminescence marker. This phase
was mixed with an aqueous phase containing its particular surfactant and phase
separation occurred after equilibrium was reached. The method follows:
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1. Prepared the w/o emulsion: oil plus particular surfactant was titrated with
aqueous solution of Eu3+ and Tb3+ with GMP respectively. Ensuring that
the luminescent marker was added in the same ratio of energy transfer
found in the emission experiments, as Eu(III) to GMP, ratio 1:11 with
concentrations, Eu(III)at 40µM and GMP at 444 µM. And TB(III) to
GMP, ratio 1:10.7 with concentrations, TB(III)at 40µM and GMP at 428
µM. The process of preparation of the water in oil emulsion for the L-α
Phosphaditylcholine surfactant began by measuring 5 mL (weight was
4.94g)

of

α-tocopherol

and

mixed

with

0.0019g

of

L-α

phosphaditylcholine (500 µM). Likewise, measured 5 ml of α-tocopherol
(weight was 4.72g) and mixed with 0.006 g of palmitic acid (500 µM).

After the previous solution was made and in the process to be titrated with
luminescence marker, it must be sonicated until no more water solution
could be intake by the emulsion. The L-α phosphaditylcholine emulsion
titrated by the Eu(III) and GMP solution had a maximum intake 700 µL of
the marker. The Palmitic Acid emulsion had a maximum intake of 1200
µL. In the same way, the L-α phosphaditylcholine emulsion titrated by the
TB(III) and GMP solution had a maximum intake of 1200 µL and for the
palmitic acid emulsion the maximum value of intake was 1500 µL.

2. Sonicated the mixture for 1 hour, then centrifuged for 15 minutes at 13000
rpm. Decanted fluid.
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3. Mixed w/o emulsion of step 1 with aqueous solution of surfactant L-α
phosphaditylcholine or palmitic acid respectively. The aqueous solution
was prepared at a concentration of (250 µM) as follows:
22 mL of de-ionized water were measured and mixed with 0.0043 g of L-α
phosphaditylcholine.

The second solution consisted of 22 mL of de-

ionized water, mixed with 0.0014 g of Palmitic acid.
4. Formation of double emulsion.

The addition of w/o to an aqueous

surfactant solution formed a milky inverse emulsion.
5. Sent samples to outside laboratory to find particle size through TEM
images.

Cell study
Cell penetration study was performed to assess the diffusion and the releasing of
the biosensor into the cells.

We obtained a good encapsulation of the

hydrophobic luminescence biosensor (rivoflavin + rifampicin). The cell study was
performed with this hydrophobic nanoparticle. Cells obtained from ATCC were
grown per the prescribed protocol (see below Cell Preparation Procedure); cell
plates were washed with PBS two times. Then into a 24 well plate, 1mL of PBS
was placed into 17 wells. Placement on the plate were as follows: by columns on
the plate (4 wells) from left to right the following concentration of 0, 200, 400,
and 800 uL of the nanoparticle and 1 well (5th column) had 1000 uL of the
nanoparticle solution set as control. The plate was incubated for one hour. A cell
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lysis solution using N-lauroylsarcosine sodium salt was previously made.
Discarded the solution from the 17 wells and added 500 µL of the lysis solution in
each well, placed on an incubator shaker for overnight shake. After complete
breakthrough of cells, took emission spectra at ʎ=530.39. (Figure 30 and 31).
The maximum emission was found at ʎ=530.39 with an intensity of 14,298.

Cell Preparation Procedure
1. Prepared modified DMEM Media food starting with one 500mL bottle of
Hyclone DMEM/HIGH media. Added 50mL of Standard Fetal Bovine
Serum to DMEM/HIGH media. Additional, added 2.5 mL of Gentamycin
solution and 5.0 mL of Amphotericin B Solution to the DMEM/HIGH
media. The Amphotericin B Solution and Standard Fetal Bovine Serum
are stored in freezer. These two components must thaw out before added
to DMEM/HIGH solution. Modified DMEM media placed in incubator to
warm up to 37o C.
2. Removed 1mL ampoule from cryogenic storage container. Allowed to
thaw and placed into 750 mL flask with 50 mL modified DMEM media.
Placed cell culture in incubator at 37o C and 5.0% CO2.
3. Waited 24 hours, rinsed flasks with sterilized PBS solution twice and
added 50 mL modified DMEM media to flasks. Returned to incubator.
4. Waited 48 hours, checked progress of growth of cells. Changed modified
DMEM media with fresh modified DMEM media. Repeated this cycle
until flask was saturated with cells.
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5. Re-plated cells starting with making 9mL de-ionized water to 1 mL 10x
Trypsin solution. Drained media from flask and washed with PBS 3 to 4
times till all color was removed from flask. Added the 10mL Trypsin
solution to the flask. Spread throughout flask and kept in incubator for two
minutes. Took out of incubator and gave gently but stern slaps to the
incubator to loosen cells from flask’s walls. Checked for any cell
attachment using microscope. If still attached continue stern slapping of
flasks. Once all cells all cells are floating. Then immediately add 50 mL of
modified DMEM media, otherwise Trypsin will inactivate the cells. The
modified DMEM media inactivates the Trypsin. Added additional 20 mL
of modified DMEM media to flask. Proceeded to transfer 2 mL aliquots to
40 circular Petri dishes. Added additional 1 mL of modified DMEM media
for a total of 3 mL of solution in each Petri dish. Placed all Petri dishes in
incubator.
6. Returned 24 hours later and rinsed each Petri dish twice with PBS and
placed 5 mL of modified DMEM media into Petri dishes and placed back
in incubator to be checked at 48 hour intervals.
7. At the 48 hour interval checked progress of cells in Petri dishes on the
microscope. If dishes were not full then drained old media off and refilled
with 5 mL of fresh modified DMEM media. Placed back into incubator.
8. Once plates are full with cells, then plates can be used for further testing
such as toxicity or preliminary uptake of nanoparticles. Precautions such
as maintaining sterile conditions are extremely important. Do not touch
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tips of containers. Proper pipetting techniques should be used. Never
pipette from original bottles.

Transfer quantity needed to secondary

bottle and pipette from this bottle. Lids of flask should not be too tight.
Powder free latex gloves should be worn at all times when handling cell
cultures and washed repeatedly with a 70/30 % ethanol to de-ionized
water solution.

As previously explained, hydrophilic nanoparticles were developed; these ones
encapsulated the luminescent biosensor so cell study and toxicity were performed
as follows:

1. Had cells ready and then transferred them into the wells placing the same
amount 250µL of cells in each well. Emptied out the media and washed
the cell plates with PBS. Put 1 mL of PBS in each one of the 17 Petri
dishes.
2. Incubated plate for one hour after placing the following amount of
nanoparticles into the wells with cells:
Control (no nanoparticles), 1ml, 2ml and 3 ml, and incubate for 1 hour.
This procedure was followed for the de-ionized water in oil emulsions of
palmitic acid and The L-α phosphaditylcholine as a concentration
dependant study.
At the same time placed the biosensor (Lanthanide + GMP) into the wells
with the cells:
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For Eu (III) at a concentration of 40 µM, 80 µM and 120 µM, GMP added
at concentrations of 150 µM, 300 µM and 450 µM,
For Tb (III) at a concentration of 40 µM, 80 µM and 120 µM, GMP added
at concentrations of 150 µM, 300 µM and 450 µM.
Plates were incubated for 1 hour.
3. Took away the emulsions and do not wash with PBS.
4. Put media back and incubated for 48 hours
5. Performed toxicity test using BCA Reagent Assay Kit
Toxicity test
The BCA Protein Assay combines the well-known reduction of Cu2+ to Cu1+ by
protein in an alkaline medium with the highly sensitive and selective colorimetric
detection of the cuprous cation (Cu1+) by bicinchoninic acid. The first step is the
chelation of copper with protein in an alkaline environment to form a light blue
complex. In this reaction, known as the biuret reaction, peptides containing three
or more amino acid residues form a colored chelate complex with cupric ions in
an alkaline environment containing sodium potassium tartrate.

In the second step of the color development reaction, bicinchoninic acid (BCA)
reacts with the reduced (cuprous) cation that was formed in step one. The intense
purple-colored reaction product results from the chelation of two molecules of
BCA with one cuprous ion. The BCA/copper complex is water-soluble and
exhibits a strong linear absorbance at 562 nm with increasing protein
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concentrations. The BCA reagent is approximately 100 times more sensitive
(lower limit of detection) than the pale blue color of the first reaction (28).

The reaction that leads to BCA color formation is strongly influenced by four
amino acid residues (cysteine or cystine, tyrosine, and tryptophan) in the amino
acid sequence of the protein. However, unlike the Coomassie dye-binding
methods, the universal peptide backbone also contributes to color formation,
helping to minimize variability caused by protein compositional differences. (28)

If the biosensor is toxic, then those cells killed have detached from the plate and
are free floating. These dead cells are then rinsed away when washing the plates
with regular PBS. Therefore, the BCA test, as explained in the previous
paragraphs, is measuring the protein content from only those cells left alive that
undergo the lysis solution step. This step, (lysis) has been determined to be
highly critical in the accuracy of the toxicity test. Any large portion of a well’s
cells which are not lysis would give an undercount of the true value of absorbance
compared if all cells were lysis. Using the absorbance results obtained by the
Micro plate reader, a ratio of absorbance of each concentration dependant series
versus the three control wells’ would be determined. This ratio when translated to
a percentage would start the foundation of determining the LD50 for the given
concentration which were tested and find if the biosensor is toxic. The procedure
used is as follows:
1. Outside of the hood, washed plates twice with regular PBS
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2. Put 1 mL of lysis solution
3. Shook 15 minutes lightly at 100 rpm
4. Prepared the BCA reagent as 50 parts of reagent A and 1 part of reagent B,
a green solution was formed and the solution must be protected from the
light. Added 3 mL of working reagent per sample.
Reagent A: Bicinchonic acid and tartrate in an alkaline carbonate buffer.
Reagent B: 4% copper sulfate pentahydrate solution
5. Transferred 1.1 mL of sample in a 24 well plate, replicated three times for
each sample.
6. Used the BioTek El x800 absorbance microplate reader with Gen 5 1.09
software, and selected protocol1. Read Plates @ 570nm and 630 nm.

Fluorescence Study
1. Prepared 3 flasks of cells over a two week period. Fed cells per lab
protocol using Standard Fetal Bovine Serum with Amphotericin B and
Gentamycin.
2. Re-plated grown cells using Trypsin to make cells detach from walls of
flasks. Placed cells into five 100mm x 100mm square petri dishes this had
two 75x25mm (1.0 – 1.2mm thick) pre-cleaned plain microscope slides.
3. Cells grew for week.
4. Prepared emulsions (L-α phosphaditylcholine + de-ionized water + αtocopherol) and (palmitic acid + de-ionized water + α-tocopherol) and
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added Eu(III) + GMP and TB(III) + GMP to come up with four plates plus
one control plate.
5. Sonicated the emulsions for one hour, prepared square petri dishes,
washed with PBS twice. Placed emulsions on slides in the square petri
dishes and incubated for one and half hours.
6. Using the Olympus BX-51 microscope (fFigure 12) filtered by the
standard U-RSL 6 filter bar with attached DP 70 camera and using
Olympus DP Manager and DP Controller software captured
images (See Figure 33).
7.

Images captured were not well defined. Those images of (Palmitic
Acid + de-ionized water + α-Tocopherol) and added Eu(III) +
GMP and TB(III) + GMP were the better of the images.

8.

Grew cells for week in flask, re-plated into three square petri dishes and
let grow for another week.

9.

Sonicated only the emulsions of (palmitic acid + de-ionized water + αtocopherol) and added Eu(III) + GMP and TB(III) + GMP for two hours.
Prepared square petri dishes, washed with PBS three times. Placed
emulsions on slides in the square petri dishes and incubated this batch for
three hours.

10.

Using the Olympus BX-51 microscope filtered by the standard URSL 6 filter bar with attached DP 70 camera and using Olympus
DP Manager and DP Controller software captured images (See
Figure 34).
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3.

RESULTS AND DISCUSSION

3.a. Basic Spectroscopic Properties of Europium (Eu) and Terbium (Tb)
The absorption spectrum of the lanthanides, bases and nucleotides give us
valuable information concerning the initial step involved in any possible
photochemical process. A molecule may be excited in several different ways,
depending on the frequency of radiation absorbed.

It is anticipated that the

absorption causes displacement of outer electrons in the molecule because the
frequency of radiation is in the visible and ultraviolet region of the spectrum (29).

Europium (Eu) and Terbium (Tb) are part of the lanthanides, fifteen rare earth
metal elements in the sixth row of the periodic table. They are often referred to as
4f-metals, because each new electron added as one proceeds from Lanthanum
(La) to Lutetium (Lu) enters into the 4f-shell. Furthermore, since the 4f-shell is
located inside of the shell of the 5d6s-conduction state, the nature of the latter
changes little as a function of atomic number. The chemical properties of the
lanthanide ions are very similar, since the 4f electrons are well shielded by the 5s
and 5p electrons (30). The most impressive feature about the spectra of rare earth
(RE) ions in ionic crystals is the sharpness of the many lines in their absorption
and emission spectra. These lines can be as narrow as those commonly observed
in the spectra of free atoms of free molecules. The narrow optical lines suggest
that the interaction or rare earths (RE) ions with the crystalline environment is
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relatively weak (31). Table 4 shows some basic spectroscopic information of Eu
(III) and TB (III).

The rare earths when solids are either divalent or trivalent. By far the most
common valence state of the RE ions in solids is the trivalent state with electronic
configuration 4fN-15s25p6. The 4f electrons are clearly not the outermost electrons.
These electrons are shielded from external fields by two electronic shells with a
larger radial extension (5s25p6), this explains the atomic nature of their solid state
spectra. Due to this shielding, the 4f electrons are only weakly perturbed by the
charges of surrounding ligands. This characteristic is why RE ions is such a
useful probe in a solid. The crystal environment constitutes only a small
perturbation on the atomic energy levels and many of their solid state, hence
spectroscopic, properties can be understood from a consideration of the free ions
(32)

.

Eu (III) has been used in luminescence studies due to the unique 4f-to-4f
absorption/emission band near 580 nm which cannot be split by a ligand field.
Usually a tunable dye laser is necessary to study the Eu (III)’s 580 nm band
because of the resolution and sensitivity needed for analysis of the band shape.
Eu (III) is also the least stable lanthanide with respect to redox chemistry. It’s
reduction potential of about -3.5 V, depending on the coordination environment is
within the range of weak biochemical reducing agents.

All other trivalent

lanthanides have oxidation/reduction potentials unfavorable by 1 V or more.
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Consequently, due to either instrumental or chemical reasons, it is not always
possible to take advantage of some of the superior probe properties of Eu (III) (15).

Table 4. Basic Spectroscopic Properties of Eu & Tb in the trivalent state (32)
Atomic
Number

Element

Electron
configuration
RE(III)

63

Europium (III)

4f65s25p6

7

f0

65

Terbium (III)

4f85s25p6

7

f6

Ground Term
RE(III)

TB (III) has 4f-to-5d absorption bands which provide an alternative to the
demanding instrumental requirements of studying the 580nm band of Eu (III).
Since the 5d orbitals are immediately exposed to the ligand field, the 4f-to-5d
absorption bands move by thousands of wavelength numbers with changes in
coordination, providing a convenient monitor of site multiplicity, and chemical
exchange. However, some of the TB (III) absorption bands are too far into the
ultraviolet range to be studied with conventional fluorescent equipment and often
overlap with ligand absorption bands. Energy transfer from intrinsic fluorophores,
such as nucleic acids, generally gives rise to enhanced TB (III) (33) emission. This
is often not the case with Eu (III) if charge transfer occurs (15).
Basically, all of the lanthanide absorption bands observed in the near-infrared to
near-ultraviolet range of the spectrum are attributed to electric dipole transitions,
although these transitions are parity forbidden since they occur between states
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within the same configuration. The magnetic properties of lanthanide ions vary
appreciable along the series. The ions La (III) and Lu (III) are diamagnetic.
Among the paramagnetic ions, Pr (III), Eu (III) and Yb (III) have short electron
spin relaxation time. An extremely important application of lanthanides is the
ability to get quantitative answers to conformational problems. Enhancement of
the luminescence of Eu (III) and TB (III) ions on biding to a ligand are capable of
providing a detailed knowledge of the metal ions biding sites (30).

3.b. Absorption of Europium (Eu) and Terbium (Tb)
Lanthanides are extremely weak absorbers with Europium and Terbium having
shown weak absorption bands in the UV-Vis spectrum. No sharpness of lines are
observed in their absorption spectra. The absorption spectra of aquo-complexes
showed values of extinction coefficients (ε) in the literature for TB(III) near 310
M-1cm-1 at 220nm corresponding to the fully allowed 4f-to-5d band

(15)

. For

Eu(III) the 7F1 state was only about 360 cm-1 above the 7F0 ground state and
excitation from both levels was observed. Unlike TB (III), the Eu (III) 5d levels
lie well above 50,000 cm-1 and no 4f-to-5d absorption bands are observed above
200 nm. Like TB (III), Eu (III) had many 4f levels accessible within the visible
and ultraviolet regions yielding a large number of absorption and emission bands
(see Figure 4) (15).

For a foundation for the research, the extinction coefficients for Eu (III) and Tb
(III) were established as a measure of how strongly these lanthanides absorbed
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light at a particular wavelength. Dilutions from a stock solution generated four
different solutions with the following concentrations: 100 µM, 200 µM, 500 µM
and 1,000 µM of each one of the lanthanide ions, then the absorption of each
solution were measured. The excitation wavelength was λ =226.50 nm for Eu
(III) and the average absorbance value for all the solutions were 0.21. Likewise,
the excitation wavelength for Tb (III) was λ =221.60 nm and the average
absorbance value were 0.22.

After finding the linear equation, that represented the relationship between
concentration (X-Axis) and absorbance (Y-Axis) for the specific lanthanide ion,
the value of the molar extinction coefficient (ε) was calculated (Figures 13 and
14). The calculation based on Beer’s law found that Eu (III) molar extinction
coefficient was 457 M-1cm-1 and the one for Tb (III) was 477 M-1cm-1. The
experimental value of Tb (III) was close to the reference value of 310 M-1cm-1 at
220 nm. Details of the experimental conditions of terbium chloride in water can
be found on the cited reference (15). This wavelength presumed corresponds to the
fully allowed transition 4f- to-5d.

An expected value to compare the molar

extinction coefficient of Eu (III) was not available.

The absorption spectra of the nucleic bases were analyzed. The base adenine (A)
dissolved in water at excitation wavelength λ max=260.5 nm had a molar
extinction coefficient ε =7,772 M-1cm-1. Literature research shows that adenine
dissolved in water, pH 7, has a molar extinction coefficient of 13,400 M-1cm-1 at
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261 nm (34). Due to an expected low fluorescence yield, estimated to be 2.6x10-4 a
fluorescence spectrum was not collected (35).

The base cytosine (C) dissolved in water at excitation λ max=220.34 nm had a
molar extinction coefficient ε =6,571 M-1cm-1. Literature research shows that
cytosine dissolved in water, pH 7, has a molar extinction coefficient of 6,100 M1

cm-1 at 220 nm (34). Due to an expected low fluorescence yield, estimated to be

8.2x10-5 a fluorescence spectrum was not collected (35).

Guanine (G) dissolved in water at excitation λ max=246 nm, had a molar
extinction coefficient of ε =390 M-1cm-1. Literature research shows that guanine
dissolved in water has a molar extinction coefficient of 10,700 M-1cm-1 at 243 nm
(34)

. Due to an expected low fluorescence yield, estimated to be 3.0 x 10-4 a

fluorescence spectrum was not collected (35).

Finally, thymine (T) dissolved in water at λ max=263.2 nm, had a molar
extinction coefficient of ε =5,075 M-1cm-1.

Literature research shows that

thymine dissolved in water has a molar extinction coefficient of 7,900 M-1cm-1 at
263.75 nm

(34)

. Due to an expected low fluorescence yield, estimated to be

1.02x10-4 a fluorescence spectrum was not collected (35).
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Figure 8. Eu (III) absorption at wavelength max λ =226.5 nm
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Figure 9. Tb (III) absorption at wavelength max λ = 221.6 nm
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The same procedure was followed to measure the absorption of the nucleotides.
dATP in aqueous solution had a wavelength maxima of λ =261.55 nm and a molar
extinction coefficient of ε=13,189 M-1cm-1. Likewise dCTP in aqueous solution
had a λ max=220.32 nm and ε =7,896 M-1cm-1; dGTP had a λ max=253.28 nm
and ε =8,821 M-1cm-1; finally dTTP had a λ max=266.84 nm and ε =6,607 M-1cm1

. There were not literature values available to compare the accuracy of the

results. However, the molar extinction coefficients were similar to the values
found for the respective bases, which would be a good indication of the validity of
the nucleotides absorption results.

Based on the experimental data for wavelength maxima (λ max) and extinction
coefficient (ε), it was clear that the values for adenine and guanine were different
than the ones reported in the literature. Cytosine and to a lesser degree thymine
extinction coefficients were the only nucleotides comparable with the expected
values.

The extinction coefficient (ε) is a characteristic of the solute and

depending upon the wavelength of light, the solvent and temperature, any change
in the experimental conditions can be the cause for inaccuracy.

Literature

research states that membrane systems are probably the most difficult to study,
due to their unavoidable turbidity and tendency to settle (15). The differences in
absorption values of the nucleic acids can be attributed to its physical
characteristics. Because, centrifugation and microfiltration were not performed
on the nucleic bases or its nucleotides in order to avoid turbidity and precipitation.
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The homogeneity of the sample might be compromised in the absorption and
emission readings.

3.c. Emission of Europium (Eu) and Terbium (Tb)
The purpose of the emission experiments was to determine the best concentration
in which effective energy transfer from the donor, nucleic bases and nucleotides,
to the acceptor, trivalent ion, would occur. After many trials of adding nucleic
bases (donor molecule) to a fluorescent trivalent ion solution (acceptor ion) at
different concentrations, the best array of concentrations for efficient energy
transfer was finally devised. The initial concentration of the trivalent ions was set
at 40 µM. Aliquots were added in increments of 10 µL, of nucleic acids at 10 mM
stock solution, to each one of the trivalent ions. Similarly, aliquots were added in
increments of 10 µL, of nucleotides at 1 mM stock solution, to the respective
aqueous trivalent ions solution. We called this process, titration of the trivalent
lanthanide ion by either nucleic bases or nucleotides.

Spectra emission was

obtained but for analysis focus was on the visible spectrum. Also, notice the
excitation readings at a single wavelength were not performed.

A solution containing 40 µM Eu (III) or Tb (III) was weakly emissive upon
excitation, due to the low extinction coefficient of the lanthanide ion. Since
nucleic acids exhibit large absorption cross sections in the 250-280 nm range (1),
energy transfer (EnT) from the excited base to the emissive state 5D0 of bound Eu
(III) or 5D4 of Tb (III) is possible. Although Tb (III) excitation can involve the 5d
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levels, there is rapid internal conversion of all excited states to the 4f5D4 level,
from which virtually all the emission occurred (15). The enhanced Eu (III) or Tb
(III) luminescence in the presence of each nucleic base was established. The
relative emission intensity of 40 µM Eu (III) with increasing concentration of
each nucleic base is shown in Figures 15 and 16. Similarly, the relative emission
intensity of 40 µM Tb (III) with increasing concentration of each nucleic acid is
shown in Figures 17 and 18.

The relative emission intensity of 40 µM Eu (III) spectra at λ=375.81 nm, 486.82
nm and 542.54 nm with increasing concentration of each nucleic bases displayed
decreasing behavior for overall luminescence for A (adenine), C (cytosine) and T
(thymine). As the aliquots at the following concentration; A (adenine 9.88 mM),
C (cytosine 10 mM), and T (thymine 10.05 mM) were increased, there was no
enhancement of Eu (III).

Significant enhancement of the Eu (III) emission

intensity at λ=375.81 nm and 542.54 nm was observed upon addition of G
(guanine) which was quite the opposite of A, C, and T. (Figure 15 and 16).

The relative emission intensity of 40 µM Tb (III) spectra at λ =375.81 nm and
542.54 nm with increasing concentration of each nucleobase showed decreasing
behavior in the overall luminescence for adenine, cytosine and thymine bases. As
the aliquots at the following concentration; A (adenine 9.88 mM), C (cytosine 10
mM), and T (thymine 10.05 mM) were increased, there was no significant
enhancement of Tb (III). In contrast, important enhancement of the Tb (III)
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emission intensity at λ =375.81 and 542.54 nm was observed upon addition of G
(Figure 17 and 18).

From the analysis of the emission results with nucleic bases, it was deduce that
only one of the bases showed effective enhancement.

Guanine displayed

emission for both Eu (III) and Tb (III). It is known that strong chelation of Tb(III)
in water is better accomplished by ligands that possess two or more adjacent
electron density rich regions, especially when at least one of them is an oxygen
atom

(36)

. Inspection of the structures of the nucleic acids (Figure 1) revealed that

this is only possible in C (through O2 and N3) and G (through O6 and N7). The
difference in enhancement between C and G may be due to differences in
quantum yield or triplet state formation or differences in binding stability and
kinetics (1).

The relative emission intensity of 40 µM Eu(III) and Tb(III), at λ=375.81 nm and
542.54 nm was measured as the concentration of

2’ Deoxy 5’-triphosphate

disodium salt of each nucleobase, dATP, dCTP, dGTP and dTTP, was increased
(Figure 19 through 22).

It was expected that dGTP or dCTP would show

luminescence enhancement. Surprising results were obtained when none of the
nucleotides showed emission.
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Figure 10. Emission of Eu (III) with nucleobases at λ=375 nm
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Figure 11. Emission of Eu (III) with nucleobases at λ =542.54 nm
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Figure 12. Emission of Tb (III) with nucleobases λ =375 nm
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Figure 13. Emission of Tb (III) with nucleobases at λ =542.54 nm
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Apparently, there was no energy transfer due to phosphate interference and
impractical binding with the three phosphates available for complexation (Figure
2, dGTP). Previous studies measured the emission intensity of 25 µM of Tb (III)
as the concentration of that 5’ deoxymonophosphate disodium salt of each
nucleobase, dAMP, dCMP, dGMP, and dTMP was increased. As previously
reported, only dGMP, showed enhancement of Tb (III) emission (1). Therefore, we
performed fluorescence experiments using 5’-monophosphate disodium salt of
each nucleobase, at concentration of 1 mM respectively (Figure 2, GMP).

The relative emission intensity of Eu(III) and Tb(III) spectra at λ=486.82 nm and
542.54 nm was measured as the concentration of the 5’-monophosphate disodium
salt of each nucleobase (1mM), AMP, CMP, GMP and TMP, was increased
(Figure 23 through 26).

Only GMP showed a slight enhancement of the Eu (III) emission at 486 nm but
no enhancement at 542 nm (Figure 23 and 24). Addition of similar concentrations
of AMP, CMP, and TMP to Eu (III) did not appear to enhance the luminescence
of the lanthanide ion.

Relatively, for Tb (III), GMP showed considerable

enhancement of the Tb (III) emission at both wavelengths 486 nm and 542 nm
(Figure 25 and 26). A negligible degree of enhancement for Tb (III) was formed
by addition of AMP at 486 nm but not at 542 nm.

Addition of similar

concentrations of CMP, and TMP to Tb (III) did not appear to enhance the
luminescence of the lanthanide ion.
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Figure 14. Emission of Eu (III) with triphosphate nucleotides at λ=375 nm
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Figure 15. Emission of Eu (III) with triphosphate nucleotides at λ =542.54 nm
Emission of Eu+3 with Nucleotides
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Figure 16. Emission of Tb (III) with triphosphate nucleotides at λ =375 nm
Emission of Tb3+ with Nucleotides
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Figure 17. Emission of Tb (III) with triphosphate nucleotides at λ =542.54 nm
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As reported previously by various authors, dGMP led to enhancement of the Tb
(III) emission, whereas the other nucleotides did not

(37) (1)

. Comparably, the

emission experiments found the base, guanine (G), and its nucleotide, 5’monophosphate disodium salt (GMP), enhanced the luminescence of both
trivalent ions. Among the bases and nucleotides, GMP, was the ligand that
enhanced the luminescence of both lanthanide ions to a greater extent. However,
GMP bound to Tb (III) appeared to be more emission efficient than bound Eu
(III). The difference in emission could be explained based on water interference,
deactivation pathway, or/and energy transfer (EnT) efficiency parameters.

First, it is believed that Eu (III) sensitive emission state is weaken by water
molecules interference and its deactivation pathway is affected. Upon ligand
excitation in the presence of Tb (III) or Eu (III) two mechanisms for the
enhancement of the lanthanide emission are possible in water. Energy transfer
from the excited ligand to Tb (III) or Eu (III) is expected to provide the largest
enhancement, although a small increase in the emission intensity could arise from
the replacement of water molecules from the first coordination sphere of the ion
by other ligands, resulting in a decrease of the excited state deactivation through
the O-H vibrational modes of coordinated water molecules. Whereas the former
is dependent on the excitation wavelength (where the ligand absorbs), the latter is
not. However the emissive state of Tb (III) is not as sensitive to water vibronic
deactivation compare to that of Eu (III) (1). Since the coordination sphere of the
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lanthanide ion is saturated by the ligand, the ability of water to quench the
luminescence is small (25).

Second, the difference in emission between, bound Eu (III) and Tb (III) can be
justified by EnT parameters. Energy transfer (EnT) takes place from the excited
base of a given base (donor) to the emissive state 5D0 of bound Eu (III) or 5D4 of
Tb (III).

The efficiency of the EnT process depends on the binding of the

lanthanide to the base, rate of energy transfer, and quantum yield of formation of
the ligand donor excited state. The study of these efficiency parameters is out of
the scope of our research but nevertheless helps in the explanation of the
lanthanides fluorescence behavior. It is believed that the emission differences
between the two lanthanide complexes could be explained by either the quantum
yield of formation of the triplet state of the donor or to differences in binding of
Eu (III) to each nucleotide.

It has been reported that cytosine (C) and dGMP had the best EnT performance
when bounded to Tb (III). That study established excited-state kinetics of the
nucleotides is known to be very similar to those of the corresponding bases

(1)

.

So, being cytosine, a great ligand, we expected that dCMP followed the trend.
However, CMP bounded to the lanthanide ions was not emissive at all. The
observed differences in energy transfer to the lanthanide ion between CMP and
GMP could be explained by variations in binding of the trivalent ion in the
presence and absence of the anionic phosphate group. It appeared that in CMP
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the Tb (III) and Eu (III) bounded to the phosphate group could be too far away
from the base for effective energy transfer. The difference between GMP and
CMP could be due to the ability of the phosphate to fold over and interact with the
lanthanide ions trough O6 and N7 in GMP, whereas an analogous fold over in
CMP did not take place. In the cases of G and GMP, the phosphate group
appeared to aid in binding of the donor and acceptor. Research had shown that
GMP is a better energy transfer donor in the order GMP> GDP > GTP

(16) (17)

.

This fact is supported by the initial experiments where dGTP did not show any
enhancement for the trivalent ions.

When we replaced the triphosphate by

monophosphate, the process of energy transfer happened.

The difference in

binding between dGTP and GMP can be explained in terms of phosphate
interference and molecular geometry for the binding with the trivalent ions.

The emission experiments discovered the best ratio for effective energy transfer
(Figure 27). The ratios were: Eu (III) to GMP 1:11 and Tb (III) to GMP 1:10.7.
The concentrations at which effective EnT happened were: Eu (III) plus GMP at
444 µM; and Tb (III) plus GMP at 428 µM.
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Figure 18. Emission of Eu (III) with monophosphate nucleotides λ =542.54 nm
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Figure 19. Emission of Eu (III) with monophosphate nucleotides λ =486.82 nm
Emission of Eu+3 with Monophosphate Nucleotides
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Figure 20. Emission of Tb (III) with monophosphate nucleotides λ =542.54 nm
Emission of Tb+3 with Monophosphate Nucleotides
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Figure 21. Emission of Tb (III) with monophosphate nucleotides λ =486.82 nm
Emission in Tb+3 with Monophosphate Nucleotides
ʎ=486.82
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Figure 22. Energy transfer of complex Eu (III) + GMP and Tb (III) +GMP
Emission of Eu+3 & Tb+3 with Monophosphate
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ʎ=542.54
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3.d. Design of Nanoparticles
After finding the best ratio for efficient EnT, the fluorescence biosensor has to be
transported into the cells. As a means of delivery system, nanoparticles can
encapsulated and protect the biosensor. One way to create the nanoparticles is
through the formation of nanoemulsions. Nanoemulsions are a class of emulsions
with a droplet size between 20 and 500 nm (38). Their droplets are stabilized by
surfactants. They are not formed spontaneously; their properties depend not only
on thermodynamic conditions but on preparation methods and the order of
addition of components. Nanoemulsions can be used as micro reactors of
controlled size for the preparation of mono-disperse particles (38).
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We followed two different design schemes. The first one was based on Governors
State University thesis research about Rifampicin, an antibiotic that has been
widely used as an anti-tubercular drug. It has been shown that the nanoparticles
with PLGA-PEG polymer combination increase the hydrophilicity of Rifampicin
(RIF), a hydrophobic drug. Using the highly fluorescence property of Rifampicin
as a tool, it was proven that the drug was encapsulated successfully

(26)

. The

thesis work, “Photo Physical Properties of Non- Encapsulated and Encapsulated
Rifampicin: A comparative study”, was the base for becoming familiar with the
methods and measurement of fluorescence nanoparticles. A TEM picture of the
encapsulated RIF inside the NP is shown in figure 28.

The second scheme was the design of double or inverse emulsions (w/o/w) to
create nanoparticles (Figure 29). Several surfactants were tested to encapsulate
the hydrophilic biosensor. After extensive literature research and experimentation,
two surfactants were chosen for the nanoparticles production. One surfactant was
palmitic acid and the other L-α phosphaditylcholine (known as lecithin).

We selected these two surfactants based mainly on their compatibility with
biological systems, their stability during storage, and efficacy after administration
into the body. First, L-α phosphaditylcholine, is a major structural component of
cellular membranes in eukaryotic cells. Secondly, phosphatidylcholine serves as
a reservoir for several lipid messengers. Finally phosphatidylcholine is used for
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preparation of vesicle suspensions commonly called liposomes or as monolayers
(39)

.
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Figure 23. Hydrophobic nanoparticles

Figure 24. Hydrophilic nanoparticles
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Similarly, palmitic acid or hexadecanoic acid is one of the most common
saturated fatty acids found in animals and plants and has low toxicity. We sent
our nanoparticles with the encapsulated biosensor to University of Illinois at
Chicago for proper assessment of particle size due to the lack of TEM equipment
(transmission electronic microscope). Our findings can be visualized in Figure
29, which shows the encapsulation of the biosensor into 75 nm particles made of
palmitic acid.

We tested the efficiency of the nanoparticles delivery into the cells.

The

hydrophobic nanoparticles, made of a combination of PLGA-PEG polymer, were
added into cells we had previously grown.

The initial checks for emission were hampered due to the difficulty in the cells
lysing.

After sonication and shaking for several days, two separate samples

(Figure 30 and 31) that displayed emission were obtained. Figure 30 exhibited
the fact the NP had entered into the cells. Figure 31 showed such a high emission
that the NP’s themselves had fragmented besides the cells bursting. The highly
fluorescence property of Rifampicin as a tool proved that the drug is encapsulated
successfully.
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Figure 25. Emission of hydrophobic nanoparticles.
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Figure 26. Bursting of hydrophobic nanoparticles.
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Similarly, the emission of the palmitic acid nanoparticles that encapsulated the
hydrophilic biosensor was tested. Unfortunately, the particle size for the L-α
phosphaditylcholine nanoparticle was not appropriate for analysis. The emission
result for the palmitic acid nanoparticles is shown in Figure 32. It was clear that
GMP enhanced the emission of the lanthanide Tb (III) in a higher degree than Eu
(III). The addition of a surfactant like palmitic acid to the solution aided the
luminescence enhancement of the ligand-lanthanide complex.

Adding this

surfactant created inverse micelles that helped in the formation of nonpolar
regions in an aqueous solution. When the complex was added in vitro, there was
a sustained release.

The initial burst released the luminescence biosensor

effectively, confirming that the nanoparticles burst and the protein was released.
In contrast, since GMP led to a lesser degree of enhancement of Eu (III), the
complex added in vitro did not show release of the biosensor. This behavior
suggested that most of the proteins remained in the nanoparticles.

The performance of Eu (III) complex can be explained by the EnT mechanism
and impurities that may affect the biosensor emission. It is believed that GMP is
usually remote relative to bounding the lanthanide Eu (III), so the effect in EnT is
weaker than in Tb (III) and the emission fluorescence effect is reduced. Also, the
formation of impurities such as Eu (II) ion may diminish the emission. The in
vitro results were in agreement with the findings of the emission studies. Tb (III)
was a better quencher than Eu (III) when bound to dGMP, and its emission in
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vitro studies reinforced this fact.

Encapsulation of the biosensor offered

successful delivery of it inside the cells.

Figure 27. Fluorescence of encapsulated Eu (III) and Tb (III)
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Finally to confirm the fluorescence release of the biosensor into the cells, pictures
of the emission of the nanoparticles were taken.

This was done using the

fluorescence capturing capability of the Olympus BX-51 microscope in
conjunction with the DP 70 camera , the picture was taken under oil (oil is place
on the slide), and the size magnification means 100X multiplied by 10X equaled
1000X (times) magnification.

Figure 33 shows the fluorescent L-α

phosphaditylcholine nanoparticles, in which the nanoparticles’ size, were not
reach. Figure 34 shows the emission of 75 nm palmitic acid nanoparticles.
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Figure 28. Fluorescence of L-α phosphaditylcholine NPs into the cells

Figure 29. Fluorescence of palmitic acid NPs into the cells

3.e. Toxicity Study
The in vitro toxicity of the nanoparticles, with both luminescence
biosensors, was assessed by BCA assay. As shown in Figure 35, the results were
satisfactory. The nanoparticles were non toxic and all their values were above the
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LD50 (Lethal Dose 50%). An LD50 is a standard measurement of acute toxicity
that is shown as percentage of cells growth as concentration dependant in
milligrams (mg) of biosensor per kilogram (kg) of nanoemulsion.
The acute toxicity values of LD50 represented the individual dose required to kill
50 percent of a population of cells. Because LD50 values are standard
measurements, it might be possible to compare relative toxicities among
biosensors. The lower the LD50 dose, the more toxic the biosensor will be.
.Using the absorbance results obtained by the micro plate reader, a ratio of each
sample concentration versus the three control wells’ absorbance would be
determined. This ratio was translated to a percentage. The biosensor of Eu (III)
53% value represents that almost half of the cell population still alive, at the same
concentration, the biosensor of Tb (III) showed 88% of the cell population
survived.

Results supported that both luminescence nanoparticles biosensors

were non toxic. Nanoparticles of Eu (III) seemed to be more toxic than the ones
of Tb (III).
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Figure 30. Biosensor Acute Toxicity
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4.

CONCLUSIONS

The lanthanides trivalent ions, Eu (III) and Tb (III), prove their importance as
luminescent biosensors. The luminescence enhancement of Eu (III) and Tb (III)
emissions was utilized to probe the interaction between nucleic bases and the
trivalent ions. It was found that guanine enhances both of the trivalent ions
emissions with Tb (III) being a better acceptor.

The unanticipated results of lacking enhancement for the base cytosine bounded
to Tb (III) and Eu (III) is difficult to explain. First, minor fluorescent impurities
can make significant contributions and may contribute to wrong results. Second,
unpolarized excitation light, such as “natural light” will lead to a photo selection
of fluorophores. Finally, as discussed in the poster presentation in Hawaii,
problem with luminescence in an aqueous solution is that another pathway is
available for deactivation of the excited state of the lanthanide, in the form of
vibrational energy transfer to water molecules in particular. This quenching of
luminescence was minimized by using ligands which tended to encapsulate the
lanthanide ion. Furthermore, supported by literature findings, energy transfer
from intrinsic fluorophores, such as nucleic acids, generally give rise to enhanced
Tb (III) emission. This is often not the case with Eu (III) if charge transfer occurs
(15)

.

The Luminescence enhancement of Eu (III) and Tb (III) was used to probe the
interaction between the nuclei bases and the deoxytriphosphate bases. It was
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found the base Guanine enhanced the luminescence of both lanthanides but dGTP
did not, indicating that the lanthanide bound to the phosphate group is too far
away from the base for effective energy transfer. Eu (III) is generally found to be
a more effective quencher than Tb (III).
The advantage offered by fluorescence measurements (over the absorption) are
the greater sensitivities and lower concentration limits achievable with the
excitation spectra.

The w/o/w double emulsion technique successfully created nanoparticles which
encapsulated the water soluble biosensor. The particle size achieved was 75nm,
which falls into the nanoemulsions range. Accomplished was the release of the
biosensor in vitro and the stability of the emulsion was proved. The nanoparticles
could be easily concentrated in the lymphatic system by intramuscular injection
with no toxic effects.
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5.

FUTURE GOALS

A researcher could gain further information about the topography of the
biosensor, by variation of conditions, such as pH, ionic strength, viscosity and
temperature.

Also, a good measurement of efficient EnT would be the

determination of fluorescent lifetime. In addition, the designing of an emission
system to maximize the energy transfer by single strand DNA, (SSDNA),
encapsulation instead of inverse micelles nanoparticles.

In the area of nanoparticles characterization, it would be valuable to analyze
particle size of the nanoparticles by dynamic light scattering (DSL) technique, to
get a more accurate idea of particle size distribution.

A researcher could assess the interaction of the nanoparticle with lipoproteins in
blood that may lead to premature release of the marker. By increasing the
permanence of the phospholipids nanoparticles could increase blood circulation
times and with the enhanced stability could control in vivo release of the
biosensor.
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